2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N14110
    Curromycin B 97412-77-6 98%
    Curromycin B has antibacterial activity against Gram-positive bacteria such as Bacillus subtilis. Curromycin B can inhibit the replication of human immunodeficiency virus (HIV), inhibit mouse melanoma B16 and leukemia P388 cells.
    Curromycin B
  • HY-N14111
    Cuevaene A 1246172-08-6 98%
    Cuevaene A can be isolated from the strain of gdmAI-disrupted Streptomyces sp. LZ35 and. Cuevaene A displays moderate activity against Gram-positive bacteria (e.g., Bacillus subtilis strain ATCC 11060) and modest activity against fungi (e.g., Fusarium verticillioides strain S68 and Rhizoctonia solani strain GXE4).
    Cuevaene A
  • HY-N14112
    Cuevaene B 274684-11-6 98%
    Cuevaene B can be isolated from the strain of gdmAI-disrupted Streptomyces sp. LZ35 and. Cuevaene B displays moderate activity against Gram-positive bacteria (e.g., Bacillus subtilis strain ATCC 11060) and modest activity against fungi (e.g., Fusarium verticillioides strain S68 and Rhizoctonia solani strain GXE4).
    Cuevaene B
  • HY-N14113
    Cytosaminomycin D 157878-05-2 98%
    Cytosaminomycin D is an anticoccidial agent that can be isolated from Streptomyces sp. Cytosaminomycin D shows anticoccidial activity at 2.5 μg/mL with a 100% inhibition rate.
    Cytosaminomycin D
  • HY-N14115
    γ-Chloronorvaline 76265-38-8 98%
    γ-Chloronorvaline has the activity of resistance to Pseudomonas aeruginosa, Serrata, Klebsiella pneumoniae and Bacillus subtilis in the synthetic medium, but has no effect on Escherichia coli.
    γ-Chloronorvaline
  • HY-N14117
    Curvulic acid 652-55-1 98%
    Curvulic acid has weak activity against Gram-positive and negative bacteria.
    Curvulic acid
  • HY-N14118
    Chloropolysporin B 105650-11-1 98%
    Chloropolysporin B has strong activity of anti-Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and enterococcus bacteria.
    Chloropolysporin B
  • HY-N14119
    Chloropolysporin C 105650-12-2 98%
    Chloropolysporin C has strong activity of anti-Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and enterococcus bacteria.
    Chloropolysporin C
  • HY-N14121
    Cladosporide A 310897-84-8 98%
    Cladosporide A is found in the strain of Cladosporium sp. IFM 49189. Cladosporide A inhibits Aspergillus fumigatus with IC50 of 0.5-4.0 μg/mL, but it has no effect on other filamentous fungi.
    Cladosporide A
  • HY-N14122
    Cladosporide B 376368-81-9 98%
    Cladosporide B is found in the strain of Cladosporium sp. IFM 49189. Cladosporide B has slightly stronger anti-Aspergillus fumigatus activity than Cladosporide A.
    Cladosporide B
  • HY-N14125
    Chloroquinocin 585533-78-4 98%
    Chloroquinocin has moderate activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
    Chloroquinocin
  • HY-N14128
    Cirramycin B1 57425-25-9 98%
    Cirramycin B1 has the activity against Gram-positive bacteria, Gram-negative bacteria and mycoplasmas.
    Cirramycin B1
  • HY-N14129
    Citreamicin β 128999-30-4 98%
    Citreamicin β has anti-Gram-positive aerobic and anaerobic bacterial activities.
    Citreamicin β
  • HY-N14130
    Cyclothialidine B 194276-76-1 98%
    Cyclothialidine B inhibits escherichia coli DNA helicases with an IC50 of 0.7 μM.
    Cyclothialidine B
  • HY-N14131
    Cyclothialidine D 194276-78-3 98%
    Cyclothialidine D inhibits escherichia coli DNA helicases with an IC50 of 0.7 μM.
    Cyclothialidine D
  • HY-N14132
    Cyclothialidine E 194276-79-4 98%
    Cyclothialidine E inhibits escherichia coli DNA helicases with an IC50 of 0.7 μM.
    Cyclothialidine E
  • HY-N14133
    Enaminomycin A 68330-49-4 98%
    Enaminomycin A has activity against Gram-positive bacteria, Gram-negative bacteria and plant pathogenic fungi (weak), and it has the inhibitory effect of L-1210.
    Enaminomycin A
  • HY-N14134
    Deoxyfrenolicin 10023-11-7 98%
    Deoxyfrenolicin is a quinone antibiotic that can be isolated from the fermentation broth of the Streptomyces roseofulvus strain AM-3867. Deoxyfrenolicin belongs to the frenolicin class of antibiotics. Deoxyfrenolicin exhibits antibacterial activity in vitro and can effectively inhibit the activity of Mycoplasma gallisepticum.
    Deoxyfrenolicin
  • HY-N14135
    Cystothiazole A 207399-36-8 98%
    Cystothiazole A has antifungal activity. Cystothiazole A can inhibit candida albicans, saccharomyces cerevisiae and aspergillus smoke with MIC values of 0.4 μg/mL, 0.1 μg/mL and 1.6 μg/mL, respectively. Cystothiazole A also inhibits human tumor cell, such as HPT-116 and K562 cells with MIC values of 130 ng/mL and 110 ng/mL, respectively. Cystothiazole A has no anti-bacterial effect.
    Cystothiazole A
  • HY-N14136
    Cinnatriacetin A 244277-14-3 98%
    Cinnatriacetin A is found in the strain of Fistulina hepatica. Cinnatriacetin A has only anti-Gram-positive bacterial activitys.
    Cinnatriacetin A
Cat. No. Product Name / Synonyms Application Reactivity